Health Minister Datuk Seri Dr Dzulkefly Ahmad announced measures to safeguard Malaysia’s healthcare industry amidst uncertainties over potential U.S. tariffs. The Ministry of Health is exploring alternative sources for generic medicines and medical devices from China and India to reduce reliance on U.S. and European imports.
Contents
Health Ministry Acts to Counter U.S. Tariff Challenges
With RM162.47 million worth of contracts expiring in 2026, the National Pharmaceutical Regulatory Agency (NPRA) will fast-track registration for generic products. Malaysia’s exports, including medical devices and pharmaceuticals, face rising costs due to tariff risks.
Dr Dzulkefly urged close monitoring and collaboration, emphasizing opportunities amidst challenges in securing affordable healthcare solutions.
Follow us on:
Read More News at #latestmalaysia #BusinessNews and #WorldFuture
